PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 129 | 2 | 222-225
Article title

Effects of 60 MeV Protons and 250 kV X-Rays on Cell Viability

Content
Title variants
Languages of publication
EN
Abstracts
EN
Particle radiotherapy such as the one using proton beams, provides a successful treatment approach in many cancer types. However, the cellular and molecular mechanisms by which proton irradiation induces cell death, particularly in a human peripheral blood lymphocyte model has not been examined in detail. Comparative studies of the biological effects, such as cell death, of particle therapy versus conventional X-rays treatment are of utmost importance. Here, we compared the viability of human peripheral blood lymphocyte following in vitro irradiation with protons (therapeutic 60 MeV proton beam) and photon beam (250 kV, X-rays), by applying separate doses within the range of 0.3-4.0 Gy. Cell viability was assessed 1 and 4 h after irradiation with protons and X-rays by the FITC-Annexin V labelling procedure (Apoptotic & Necrotic & Healthy Cells Quantification Kit, Biotium). Results showed that irradiation with both radiation types reduced the number of viable cells in a dose-dependent manner, as assessed as a function of the duration of post-irradiation time. Protons proved more fatal to the cells treated than X-ray photons. This demonstrates a difference in cell viability after irradiation with protons and photons in a human peripheral blood lymphocyte model.
Keywords
EN
Contributors
author
  • Department of Experimental Physics of Complex Systems, Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
author
  • Department of Experimental Physics of Complex Systems, Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
author
  • Marian Smoluchowski Institute of Physics, Jagiellonian University, Kraków, Poland
author
  • Cyclotron Center Bronowice, Proton Radiotherapy Group, Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
author
  • National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
author
  • Cyclotron Center Bronowice, Proton Radiotherapy Group, Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
author
  • Department of Epidemiology, Chair of Epidemiology and Preventive Medicine, Jagiellonian University, Medical College, Kraków, Poland
References
  • [1] F. Tommasino, M. Durante, Cancers 7, 353 (2015), doi: 10.3390/cancers7010353
  • [2] O. Keta, D. Todorović, N. Popović, L. Korićanac, G. Cuttone, I. Petrović, A. Ristić-Fira, Arch. Med. Sci. 10, 578 (2014), doi: 10.5114/aoms.2014.43751
  • [3] K.B. Lee, K.R. Kim, T.L. Huh, Y.M. Lee, Int. J. Oncol. 33, 1247 (2008), doi: 10.3892/ijo_00000115
  • [4] K.B. Lee, J.S. Lee, J.W. Park, T.L. Huh, Y.M. Lee, Exp. Mol. Med. 40, 118 (2008), doi: 10.3858/emm.2008.40.1.118
  • [5] J. Miszczyk, K. Rawojć, A. Panek, J. Swakoń, P.G. Prasanna, M. Rydygier, Radiother. Oncol. 115, 128 (2015), doi: 10.1016/j.radonc.2015.03.003
  • [6] A. Panek, A. Karabin, J. Gębicki, A. Cebulska-Wasilewska, in: Rapid Diagnosis in Populations at Risk from Radiation and Chemicals, Eds. A. Cebulska-Wasilewska, A.N. Osipov, F. Darroudi, NATO Science for Peace and Security Series E: Human and Societal Dynamics, Vol. 73, IOS Press, Amsterdam 2010, p. 255
  • [7] E. Bakewicz, A. Budzanowski, R. Taraszkiewicz, Nukleonika 48, 117 (2003)
  • [8] J. Swakoń, P. Olko, D. Adamczyk, T. Cywicka-Jakiel, J. Dąbrowska, B. Dulny, L. Grzanka, T. Horwacik, T. Kajdrowicz, B. Michalec, T. Nowak, M. Ptaszkiewicz, U. Sowa, L. Stolarczyk, M.P.R. Waligórski, Radiat. Meas. 45, 1469 (2010)
  • [9] G. Joksic, S.B. Pajovic, M. Stankovic, S. Pejic, J. Kasapovic, G. Cuttone, N. Calonghi, L. Masotti, D.T. Kanazir, Cell. Mol. Life Sci. 57, 5 (2000)
  • [10] G. Zhang, V. Gurtu, S.R. Kain, G. Yan, Biotechniques 23, 3 (1997)
  • [11] K.D. Held, Apoptosis 2, 265 (1997)
  • [12] R.A. Mitteer, Y. Wang, J. Shah, S. Gordon, M. Fager, P. Butter, H.J. Kim, C. Guardiola-Salmeron, A. Carabe-Fernandez, Y. Fan, Nature Sci. Rep. 5, 13931 (2015), doi: 10.1038/srep13961
  • [13] H. Narang, A. Kumar, N. Bhat, B.N. Pandey, A. Ghosh, Mutat. Res. 780, 35 (2015), doi: 10.1016/j.mrfmmm.2015.07.006
  • [14] M. Belli, R. Cherubini, V.M. Dalla, V. Dini, G. Esposito, G. Moschini, O. Sapora, G. Simone, M.A. Tabocchini, Int. J. Radiat. Biol. 78, 475 (2002)
  • [15] A.O. Fontana,M.A. Augsburger, N. Grosse, M. Guckenberger, A.J. Lomax, A.A. Sartori, M.N. Pruschy, Radiother. Oncol. 116, 374 (2015), doi: 10.1016/j.radonc.2015.08.014
  • [16] A.L. Edinger, C.B. Thompson, Curr. Opin. Cell Biol. 16, 663 (2004)
  • [17] N.G. Burnet, R. Wurm, J.R. Yarnold, J.H. Peacock, J. Nymn, I. Turesson, The Lancet 339, 8809 (1992), doi: 10.1016/0140-6736(92)91833-T
  • [18] D. Todorović, I. Petrović, M. Todorović, G. Cuttone, A. Ristić-Fira, J. Microsc. 232, 517 (2008), doi: 10.1111/j.1365-2818.2008.02151.x
  • [19] V.N. Ivanov, T.K. Hei, Apoptosis 19, 1736 (2014), doi: 10.1007/s10495-014-1040-x
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-appv129n217kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.